Alterity Therapeutics Ltd ADR (ATHE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 06/30
(Values in U.S. thousands)
| 06-2025 | 06-2024 | 06-2023 | 06-2022 | 06-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -7,867 | -12,541 | -9,295 | -9,321 | -11,439 |
| Depreciation Amortization | 91 | 97 | 69 | 39 | 56 |
| Accounts receivable | 67 | 3,032 | -2,653 | -325 | -3,151 |
| Accounts payable and accrued liabilities | -1,324 | 723 | -1,051 | 1,889 | 324 |
| Other Working Capital | -397 | 3,770 | -4,302 | 1,279 | -3,214 |
| Other Operating Activity | 2,015 | -3,348 | 3,743 | -2,513 | 4,475 |
| Operating Cash Flow | $-7,416 | $-8,267 | $-13,488 | $-8,951 | $-12,949 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | -4 | -5 | -65 | -8 |
| Other Investing Activity | -4,857 | 0 | -20 | 0 | 0 |
| Investing Cash Flow | $-4,857 | $-4 | $-25 | $-65 | $-8 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 27,569 | 6,653 | 213 | 12,461 | 29,318 |
| Other Financing Activity | -1,879 | -609 | -130 | -632 | -1,906 |
| Financing Cash Flow | $25,690 | $6,044 | $84 | $11,829 | $27,412 |
| Exchange Rate Effect | -129 | 171 | 616 | 2,041 | -319 |
| Beginning Cash Position | 8,185 | 10,345 | 23,432 | 20,398 | 6,872 |
| End Cash Position | 21,474 | 8,289 | 10,619 | 25,252 | 21,008 |
| Net Cash Flow | $13,289 | $-2,056 | $-12,813 | $4,855 | $14,136 |
| Free Cash Flow | |||||
| Operating Cash Flow | -7,416 | -8,267 | -13,488 | -8,951 | -12,949 |
| Capital Expenditure | N/A | -4 | -5 | -65 | -8 |
| Free Cash Flow | -7,416 | -8,271 | -13,493 | -9,015 | -12,957 |